Sweden· SE-20241014000059
GOBIVAZ 100 mg Injektionsvätska, lösning i förfylld injektionspenna
A medicinal product containing golimumab, registered in Sweden by Advanz Pharma Limited.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Golimumab
- Manufacturer
- Advanz Pharma Limited
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20241014000059
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Golimumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGOBIVAZADVANZ PHARMA Limited, Dublin
- United KingdomGobivaz 100mg/1ml solution for injection pre-filled pensAdvanz Pharma
- BelgiumGobivaz 100 mgAdvanz Pharma
- IcelandGobivazADVANZ PHARMA Limited
- NorwayGobivazAdvanz Pharma Limited
- PolandGobivazAdvanz Pharma Limited
- SpainGOBIVAZ 100 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAAdvanz Pharma Limited
- FinlandGobivazAdvanz Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Gotenfia
- Iceland · Gobivaz, Gotenfia
- Liechtenstein · Gobivaz, Gotenfia
- Norway · Gobivaz, Gotenfia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/056d494d-e2c9-4192-82e6-13e65155d07e GET /v1/drugs/056d494d-e2c9-4192-82e6-13e65155d07e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20241014000059",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20241014000059",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/gobivaz-epar-product-information_sv.pdf"
}See everything about golimumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.